Expanded Access Program for Aztreonam Lysine

Project: Research project

Project Details

Description

Expanded Access Program for Aztreonamn Lysine for Inhalation in Patients with Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection who have Limited Treatment Options and are at Risk for Disease Progression
StatusFinished
Effective start/end date1/15/0812/31/10

Funding

  • Gilead Sciences, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.